期刊
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
卷 146, 期 12, 页码 3097-3109出版社
SPRINGER
DOI: 10.1007/s00432-020-03407-3
关键词
Acute myeloid leukemia; Wnt/beta-catenin; Methylation; Gene expression; Prognosis
类别
资金
- Departamento Administrativo de Ciencia, Tecnologia e Innovacion-Colciencias [115065743926]
- Instituto Tecnologico Metropolitano-ITM Grant [P17214]
Acute myeloid leukemia (AML) is a malignant clonal disorder affecting myeloid differentiation through mechanisms that include epigenetic dysregulation. Abnormal changes in DNA methylation and gene expression profiles of pathways involved in hematopoietic development, such as Wnt/beta-catenin, contribute to the transformation, development, and maintenance of leukemic cells. This review summarizes the alterations of Wnt signaling-related genes at the epigenetic and transcriptional level and their implications for AML prognosis. Among the implications of epigenetic alterations in AML, methylation of Wnt antagonists is related to poor prognosis, whereas their upregulation has been associated with a better clinical outcome. Furthermore, Wnt target genes c-Myc and LEF-1 present distinct implications. LEF-1 expression positively influences the patient overall survival. c-Myc upregulation has been associated with treatment resistance in AML, although c-Myc expression is not exclusively dependent of Wnt signaling. Understanding the signaling abnormalities could help us to further understand leukemogenesis, improve the current risk stratification for AML patients, and even serve to propose novel therapeutic targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据